(c) 2024 PillSync.com

risperidone tablet

1 INDICATIONS AND USAGE Risperidone is an atypical antipsychotic indicated for: Treatment of schizophrenia ( 1.1 ) As monotherapy or adjunctive therapy with lithium or valproate, for the treatment of acute manic or mixed episodes associated with Bipolar Disorder ( 1.2 ) Treatment of irritability associated with autistic disorder ( 1.3 ) 1.1 schizophrenia Risperidone tablets are indicated for the treatment of schizophrenia. Efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see Clinical Studies ( 14.1 )] . 1.2 Bipolar Mania Monotherapy Risperidone tablets are indicated for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder. Efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see Clinical Studies ( 14.2 )] . Adjunctive Therapy Risperidone tablets adjunctive therapy with lithium or valproate is indicated for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder. Efficacy was established in one short-term trial in adults [ see Clinical Studies ( 14.3 )]. 1.3 Irritability Associated with Autistic Disorder Risperidone tablets are indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods. Efficacy was established in 3 short-term trials in children and adolescents (ages 5 to 17 years) [see Clinical Studies ( 14.4 )].

torrent pharmaceuticals limited


5 years ago OVAL ORANGE R2 1038 risperidone tablet

OVAL ORANGE R2 1038

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

RISPERIDONE tablets, USP 0.25 mg are yellow, oblong shaped, biconvex film coated tablets debossed with '0.25' on one side and '1035' on other side. Bottle of 30 NDC-13668-035-30 Bottle of 60 NDC-13668-035-60 Bottle of 100 NDC-13668-035-01 Bottle of 500 NDC-13668-035-05 Bottle of 9,990 NDC-13668-035-09

RISPERIDONE tablets, USP 0.5 mg are red, oblong shaped, biconvex film coated tablets debossed with 'R 0.50' on one side and '1036' on other side. Bottle of 30 NDC-13668-036-30 Bottle of 60 NDC-13668-036-60 Bottle of 100 NDC-13668-036-01 Bottle of 500 NDC-13668-036-05 Bottle of 8,500 NDC-13668-036-54

RISPERIDONE tablets, USP 1 mg are white to off white, oblong shaped, biconvex film coated tablets debossed with 'R 1' on one side and '1037' on other side. Bottle of 60 NDC-13668-037-60 Bottle of 100 NDC-13668-037-01 Bottle of 500 NDC-13668-037-05 Bottle of 4,200 NDC-13668-037-55

RISPERIDONE tablets, USP 2 mg are light orange, oblong shaped, biconvex film coated tablets debossed with 'R 2' on one side and '1038' on other side. Bottle of 60 NDC-13668-038-60 Bottle of 100 NDC-13668-038-01 Bottle of 500 NDC-13668-038-05 Bottle of 4,200 NDC-13668-038-55

RISPERIDONE tablets, USP 3 mg are yellow, oblong shaped, biconvex film coated tablets debossed with 'R 3' on one side and '1039' on other side. Bottle of 60 NDC-13668-039-60 Bottle of 100 NDC-13668-039-01 Bottle of 500 NDC-13668-039-05 Bottle of 2,750 NDC-13668-039-56

RISPERIDONE tablets, USP 4 mg are yellow, oblong shaped, biconvex film coated tablets debossed with 'R 4' on one side and '1040' on other side. Bottle of 60 NDC-13668-040-60 Bottle of 100 NDC-13668-040-01 Bottle of 500 NDC-13668-040-05 Bottle of 2,100 NDC-13668-040-57 16.2 Storage and Handling Store at 20 o to 25 o C (68 o to 77 o F); excursions permitted to 15 o to 30 o C (59 o to 86 o F). [See USP Controlled Room Temperature]. PROTECT FROM MOISTURE. Keep out of reach of children. Dispense in a tight, light-resistant container.


More pills like OVAL R2 1038












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site